Search Ontology:
ChEBI
GSK2879552
- Term ID
- CHEBI:176334
- Synonyms
-
- 4-{[4-({[(1R,2S)-2-phenylcyclopropyl]amino}methyl)piperidin-1-yl]methyl}benzoic acid
- GSK 2879552
- GSK-2879552
- Definition
- A member of the class of piperidines that is piperidine substituted by (4-carboxyphenyl)methyl and {[(1R,2S)-2-phenylcyclopropyl]amino}methyl groups at positions 1 and 4, respectively. It is a potent and irreversible inhibitor of lysine specific demethylase 1 (LSD1, also known as KDM1A). It was under clinical investigation for the treatment of acute myeloid leukaemia and small cell lung carcinoma.
- References
-
- CAS:1401966-69-5
- Chemspider:35308350
- PMID:26175415
- PMID:26710088
- PMID:27308632
- PMID:28722477
- PMID:29972300
- PMID:30472603
- PMID:30514804
- PMID:30713023
- PMID:31054890
- PMID:31249575
- PMID:31260835
- PMID:31801559
- PMID:32551003
- PMID:32850370
- PMID:32931269
- PMID:33285227
- PMID:33708617
- PMID:33833800
- PMID:34031383
- Patent:WO2012135113
- Ontology
- ChEBI ( EBI )
- is a type of
- has_role
-
Phenotype
Phenotype resulting from GSK2879552
Phenotype where environments contain GSK2879552
Phenotype modified by environments containing GSK2879552
Human Disease Model